CenterBook Partners’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
CenterBook Partners's ABVX Position: Q3 2026 in Review
CenterBook Partners increased its Abivax (ABVX) stake by 321% in Q3 2026, buying an estimated $13.1M and bringing the position to 142,496 shares worth $14.1M. The position accounts for 0.65% of the portfolio, ranked #27.
CenterBook Partners first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- CenterBook Partners held 142,496 shares of Abivax worth $14.1M as of Q3 2026.
- CenterBook Partners bought 108,685 Abivax shares in Q3 2026, an estimated $13.1M.
- Abivax made up 0.65% of CenterBook Partners's portfolio in Q3 2026, its #27 holding.
- CenterBook Partners first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- 65 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.